Skip to main content

Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.

Publication ,  Journal Article
Kaul, P; Armstrong, PW; Chang, W-C; Naylor, CD; Granger, CB; Lee, KL; Peterson, ED; Califf, RM; Topol, EJ; Mark, DB
Published in: Circulation
September 28, 2004

BACKGROUND: In a previous substudy of the GUSTO-I trial, we observed better functional and quality-of-life outcomes among patients in the United States (US patients) compared with patients in Canada. Rates of invasive therapy were significantly higher in the United States and were associated with a small mortality benefit (0.4%, adjusted P=0.02). We sought to determine whether Canadian-US differences in practice patterns in GUSTO-I had an impact on 5-year mortality. METHODS AND RESULTS: Mortality data for 23,105 US and 2898 Canadian patients enrolled in GUSTO-I were obtained from national mortality databases. Median follow-up was 5.46 years in the US and 5.33 years in the Canadian cohort. Five-year mortality rate was 19.6% among US and 21.4% among Canadian patients (P=0.02). After baseline adjustment, enrollment in Canada was associated with a higher hazard of death (1.17; 95% confidence interval, 1.07 to 1.28, P=0.001). Revascularization rates during the index hospitalization in the United States were almost 3 times those in Canada: 30.5% versus 11.4% for angioplasty and 13.1% versus 4.0% for bypass surgery (P<0.01 for both). After accounting for revascularization status as a time-dependent covariate, country was no longer a significant predictor of long-term mortality. These results were confirmed in a propensity-matched analysis. CONCLUSIONS: Our results suggest, for the first time, that the more conservative pattern of care with regard to early revascularization in Canada for ST-segment elevation acute myocardial infarction may have a detrimental effect on long-term survival. Our results have important policy implications for cardiac care in countries and healthcare systems wherein use of invasive procedures is similarly conservative.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

September 28, 2004

Volume

110

Issue

13

Start / End Page

1754 / 1760

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Survival Analysis
  • Streptokinase
  • Proportional Hazards Models
  • Practice Patterns, Physicians'
  • Myocardial Revascularization
  • Myocardial Infarction
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kaul, P., Armstrong, P. W., Chang, W.-C., Naylor, C. D., Granger, C. B., Lee, K. L., … Mark, D. B. (2004). Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I. Circulation, 110(13), 1754–1760. https://doi.org/10.1161/01.CIR.0000142671.06167.91
Kaul, Padma, Paul W. Armstrong, Wei-Ching Chang, C David Naylor, Christopher B. Granger, Kerry L. Lee, Eric D. Peterson, Robert M. Califf, Eric J. Topol, and Daniel B. Mark. “Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.Circulation 110, no. 13 (September 28, 2004): 1754–60. https://doi.org/10.1161/01.CIR.0000142671.06167.91.
Kaul P, Armstrong PW, Chang W-C, Naylor CD, Granger CB, Lee KL, Peterson ED, Califf RM, Topol EJ, Mark DB. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I. Circulation. 2004 Sep 28;110(13):1754–1760.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

September 28, 2004

Volume

110

Issue

13

Start / End Page

1754 / 1760

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Survival Analysis
  • Streptokinase
  • Proportional Hazards Models
  • Practice Patterns, Physicians'
  • Myocardial Revascularization
  • Myocardial Infarction